BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1710841)

  • 1. Acceleration of the hemopoietic reconstitution in mice undergoing bone marrow transplantation by recombinant human granulocyte colony-stimulating factor.
    Tamura M; Yoshino T; Hattori K; Kawamura A; Nomura H; Imai N; Ono M
    Transplantation; 1991 Jun; 51(6):1166-70. PubMed ID: 1710841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S; Nakao I; Tsuneoka K; Nara N
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human granulocyte colony-stimulating factor on the mice receiving bone marrow transplantation following lethal irradiation: acceleration of recovery of the peripheral blood neutrophils and potentiation of anti-Pseudomonas resistance.
    Tamura M; Matsumoto M; Yoshino T; Matsubara S; Imai N; Ono M; Yokota T
    Exp Hematol; 1991 Jan; 19(1):18-23. PubMed ID: 1703491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow.
    Scheding S; Media JE; KuKuruga MA; Nakeff A
    Blood; 1996 Jul; 88(2):472-8. PubMed ID: 8695794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
    Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effects of granulocyte colony-stimulating factor on colony-forming units-spleen (CFU-S) differentiation and pre-CFU-S proliferation in mice.
    Tanaka T; Suda T; Suda J; Inoue T; Hirabayashi Y; Hirai H; Takaku F; Miura Y
    Blood; 1991 Jun; 77(12):2597-602. PubMed ID: 1710513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
    Lazarus HM; Andersen J; Chen MG; Variakojis D; Mansour EG; Oette D; Arce CA; Oken MM; Gerson SL
    Blood; 1991 Aug; 78(3):830-7. PubMed ID: 1859894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of granulocyte colony-stimulating factor to recipients followed by intra-bone marrow-bone marrow transplantation accelerates acceptance of allogeneic bone marrow cells in mice.
    Suzuki Y; Adachi Y; Zhang Y; Minamino K; Iwasaki M; Mukaide H; Shi M; Nakano K; Koike Y; Wang J; Koike-Kiriyama N; Shigematsu A; Yanai S; Ikehara S
    Immunobiology; 2008; 213(5):427-35. PubMed ID: 18472051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.
    Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi S; Tanaka J; Zhu X; Kobayashi M; Fujii Y
    Transplantation; 1994 Jul; 58(2):214-23. PubMed ID: 7518976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.
    Johnsen HE; Hansen PB; Plesner T; Jensen L; Gaarsdal E; Andersen H; Hansen SW; Birgens H; Jacobsen GK; Kjaersgaard E
    Bone Marrow Transplant; 1992 Sep; 10(3):229-34. PubMed ID: 1384899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice.
    Bungart B; Loeffler M; Goris H; Dontje B; Diehl V; Nijhof W
    Br J Haematol; 1990 Oct; 76(2):174-9. PubMed ID: 1709805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor.
    Vannucchi AM; Grossi A; Rafanelli D; Ferrini PR
    Blood; 1990 Oct; 76(8):1473-80. PubMed ID: 2207322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.